Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF- inhibitors
From MaRDI portal
(Redirected from Publication:1743540)
Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
Recommendations
- Optimal control of mathematical models for the radiotherapy of gliomas: the scalar case
- Optimal control applied to immunotherapy
- An optimal control problem in cancer chemotherapy
- Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model
- On optimal delivery of combination therapy for tumors
Cites work
- scientific article; zbMATH DE number 3644840 (Why is no real title available?)
- scientific article; zbMATH DE number 4112436 (Why is no real title available?)
- scientific article; zbMATH DE number 3461174 (Why is no real title available?)
- scientific article; zbMATH DE number 2062254 (Why is no real title available?)
- scientific article; zbMATH DE number 3191476 (Why is no real title available?)
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- A mathematical model for cell cycle-specific cancer virotherapy
- ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
- ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Cellular immunotherapy for high grade gliomas: mathematical analysis deriving efficacious infusion rates based on patient requirements
- Geometric optimal control. Theory, methods and examples
- Introduction to the mathematical theory of control
- Modeling of cancer virotherapy with recombinant measles viruses
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments
- On optimal delivery of combination therapy for tumors
- On the dynamics of tumor-immune system interactions and combined chemo- and immunotherapy
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- Role of optimal control theory in cancer chemotherapy
- Singular trajectories and their role in control theory
- Sufficient conditions for optimality for a mathematical model of drug treatment with pharmacodynamics
- The role of TNF- inhibitor in glioma virotherapy: a mathematical model
- Treatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical system
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
Cited in
(13)- Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response
- Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response
- On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: insights from a mathematical model
- Slow-fast model and therapy optimization for oncolytic treatment of tumors
- Optimal control of mathematical models for the radiotherapy of gliomas: the scalar case
- A mathematical model for oncolytic virus spread using the telegraph equation
- The role of TNF- inhibitor in glioma virotherapy: a mathematical model
- A strategy of optimal efficacy of T11 target structure in the treatment of brain tumor
- Treatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical system
- Mathematical modeling and optimal control problems in brain tumor targeted drug delivery strategies
- Optimal control for a bone metastasis with radiotherapy model using a linear objective functional
- Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
- Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
This page was built for publication: Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1743540)
